Operating Income (Loss) in USD of REGENERX BIOPHARMACEUTICALS INC from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
REGENERX BIOPHARMACEUTICALS INC quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q1 2023.
  • REGENERX BIOPHARMACEUTICALS INC Operating Income (Loss) for the quarter ending 31 Mar 2023 was -$305K, a 11.3% increase year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC Operating Income (Loss) for the twelve months ending 31 Mar 2023 was -$1.36M, a 0.72% increase year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC annual Operating Income (Loss) for 2022 was -$1.4M, a 5.53% decline from 2021.
  • REGENERX BIOPHARMACEUTICALS INC annual Operating Income (Loss) for 2021 was -$1.33M, a 2.62% decline from 2020.
  • REGENERX BIOPHARMACEUTICALS INC annual Operating Income (Loss) for 2020 was -$1.29M, a 2.59% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

REGENERX BIOPHARMACEUTICALS INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$1.36M -$305K +$38.9K +11.3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 -$1.4M -$309K +$58.8K +16% 01 Oct 2022 31 Dec 2022 10-K 11 Apr 2023
Q3 2022 -$1.46M -$284K +$120K +29.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 -$1.58M -$465K -$207K -80.6% 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 -$1.37M -$344K -$44.4K -14.8% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$1.33M -$368K -$76.9K -26.5% 01 Oct 2021 31 Dec 2021 10-K 11 Apr 2023
Q3 2021 -$1.25M -$404K -$124K -44.1% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$1.13M -$257K +$128K +33.2% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$1.26M -$299K +$38.7K +11.5% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$1.29M -$291K +$9.87K +3.28% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 -$1.3M -$280K +$6.04K +2.11% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$1.31M -$385K -$33.3K -9.46% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$1.28M -$338K -$15.3K -4.74% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 -$1.26M -$301K -$40.8K -15.7% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 -$1.22M -$286K +$70.8K +19.8% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$1.29M -$352K -$9.84K -2.88% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$1.28M -$323K +$41.3K +11.3% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$1.32M -$260K +$51.9K +16.7% 01 Oct 2018 31 Dec 2018 10-K 20 Mar 2020
Q3 2018 -$1.38M -$357K +$84.9K +19.2% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$1.46M -$342K -$39.1K -12.9% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$1.42M -$364K +$23.6K +6.08% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$1.44M -$312K +$33.6K +9.74% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$1.48M -$442K -$63.6K -16.8% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$1.41M -$303K +$195K +39.1% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$1.61M -$388K +$64.7K +14.3% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$1.67M -$345K +$37.6K +9.82% 01 Oct 2016 31 Dec 2016 10-K 29 Mar 2018
Q3 2016 -$1.71M -$379K +$6.4K +1.66% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$1.72M -$498K +$53K +9.62% 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017
Q1 2016 -$1.77M -$452K -$61.4K -15.7% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$1.71M -$383K -$10.9K -2.92% 01 Oct 2015 31 Dec 2015 10-K 29 Mar 2017
Q3 2015 -$1.7M -$385K +$28.8K +6.97% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$1.73M -$551K -$145K -35.6% 01 Apr 2015 30 Jun 2015 10-Q 22 Aug 2016
Q1 2015 -$1.58M -$391K -$27.4K -7.54% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$1.56M -$372K -$191K -106% 01 Oct 2014 31 Dec 2014 10-K 11 Apr 2016
Q3 2014 -$1.36M -$414K -$252K -156% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$1.11M -$406K -$160K -64.7% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$952K -$364K -$38.2K -11.7% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$914K -$181K -$88.6K -96.1% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$826K -$162K -$67.1K -71% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 -$759K -$246K -$20.8K -9.21% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$738K -$325K +$104K +24.1% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$841K -$92.2K +$771K +89.3% 01 Oct 2012 31 Dec 2012 10-K 04 Apr 2014
Q3 2012 -$1.61M -$94.5K +$1.92M +95.3% 01 Jul 2012 30 Sep 2012 10-Q 18 Nov 2013
Q2 2012 -$3.54M -$226K +$1.31M +85.3% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$4.84M -$429K +$1.17M +73.1% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$6.01M -$864K 01 Oct 2011 31 Dec 2011 10-K 16 Apr 2013
Q3 2011 -$2.02M -$428K -26.9% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 -$1.53M -$161K -11.7% 31 Mar 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 -$1.6M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$1.59M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$1.37M 01 Apr 2010 30 Jun 2010 10-Q 05 Aug 2011

REGENERX BIOPHARMACEUTICALS INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.4M -$73.5K -5.53% 01 Jan 2022 31 Dec 2022 10-K 11 Apr 2023
2021 -$1.33M -$34K -2.62% 01 Jan 2021 31 Dec 2021 10-K 11 Apr 2023
2020 -$1.29M -$32.7K -2.59% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 -$1.26M +$61.5K +4.65% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 -$1.32M +$121K +8.39% 01 Jan 2018 31 Dec 2018 10-K 20 Mar 2020
2017 -$1.44M +$229K +13.7% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$1.67M +$35.5K +2.08% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018
2015 -$1.71M -$154K -9.9% 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2017
2014 -$1.56M -$641K -70.1% 01 Jan 2014 31 Dec 2014 10-K 11 Apr 2016
2013 -$914K -$72.9K -8.67% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$841K +$5.17M +86% 01 Jan 2012 31 Dec 2012 10-K 04 Apr 2014
2011 -$6.01M -$979K -19.5% 01 Jan 2011 31 Dec 2011 10-K 16 Apr 2013
2010 -$5.03M 01 Jan 2010 31 Dec 2010 10-K 04 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.